John G Muscedere

Summary

Affiliation: Queen's University
Country: Canada

Publications

  1. doi request reprint The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection
    John Muscedere
    Department of Medicine, Queen s University, Kingston, ON, Canada
    Chest 144:39-47. 2013
  2. doi request reprint The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome
    John G Muscedere
    Department of Medicine, Queen s University, Kingston, Ontario, Canada
    J Crit Care 27:322.e7-14. 2012
  3. pmc Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials
    Daren K Heyland
    Department of Medicine, Queen s University, 76 Stuart Street, Kingston, ON K7L 2V7, Canada
    Crit Care 15:R98. 2011
  4. pmc Enhanced protein-energy provision via the enteral route in critically ill patients: a single center feasibility trial of the PEP uP protocol
    Daren K Heyland
    Department of Medicine, Queen s University, Kingston, ON, Canada
    Crit Care 14:R78. 2010
  5. ncbi request reprint Venous thromboembolism in critical illness in a community intensive care unit
    John G Muscedere
    Department of Medicine, Kingston General Hospital and Queen s University, Kingston, Ontario, Canada K7L 2V7
    J Crit Care 22:285-9. 2007
  6. doi request reprint Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia
    John G Muscedere
    Queens University and 2Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada
    Clin Infect Dis 51:S120-5. 2010
  7. doi request reprint Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis
    John Muscedere
    Department of Medicine, Queen s University, Kingston, Ontario, Canada
    Crit Care Med 39:1985-91. 2011
  8. doi request reprint Determinants of outcome in patients with a clinical suspicion of ventilator-associated pneumonia
    John G Muscedere
    Department of Medicine, Queen s University, Kingston, Ontario, Canada K7L 2V7
    J Crit Care 23:41-9. 2008
  9. doi request reprint The impact of ventilator-associated pneumonia on the Canadian health care system
    John G Muscedere
    Queens University, Kingston, Canada K7L 2V7
    J Crit Care 23:5-10. 2008

Detail Information

Publications9

  1. doi request reprint The occurrence and impact of bacterial organisms complicating critical care illness associated with 2009 influenza A(H1N1) infection
    John Muscedere
    Department of Medicine, Queen s University, Kingston, ON, Canada
    Chest 144:39-47. 2013
    ....
  2. doi request reprint The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome
    John G Muscedere
    Department of Medicine, Queen s University, Kingston, Ontario, Canada
    J Crit Care 27:322.e7-14. 2012
    ..Accordingly, in patients with CSVAP and timely initiation of empiric antibiotic therapy, we determined the impact of inadequate therapy (IT)...
  3. pmc Persistent organ dysfunction plus death: a novel, composite outcome measure for critical care trials
    Daren K Heyland
    Department of Medicine, Queen s University, 76 Stuart Street, Kingston, ON K7L 2V7, Canada
    Crit Care 15:R98. 2011
    ..The objective of this study was to validate and demonstrate the utility of a novel composite outcome measure, persistent organ dysfunction (POD) plus death, for clinical trials of critically ill patients...
  4. pmc Enhanced protein-energy provision via the enteral route in critically ill patients: a single center feasibility trial of the PEP uP protocol
    Daren K Heyland
    Department of Medicine, Queen s University, Kingston, ON, Canada
    Crit Care 14:R78. 2010
    ..The purpose of this pilot study is to assess the feasibility, acceptability, and safety of a new feeding protocol designed to enhance the delivery of enteral nutrition (EN)...
  5. ncbi request reprint Venous thromboembolism in critical illness in a community intensive care unit
    John G Muscedere
    Department of Medicine, Kingston General Hospital and Queen s University, Kingston, Ontario, Canada K7L 2V7
    J Crit Care 22:285-9. 2007
    ....
  6. doi request reprint Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia
    John G Muscedere
    Queens University and 2Clinical Evaluation Research Unit, Kingston General Hospital, Kingston, Ontario, Canada
    Clin Infect Dis 51:S120-5. 2010
    ..Equivalency studies are possible, but there are sample size implications. The use of time to clinical event end points, especially when combined with mortality, may be the best option for trial in the future...
  7. doi request reprint Subglottic secretion drainage for the prevention of ventilator-associated pneumonia: a systematic review and meta-analysis
    John Muscedere
    Department of Medicine, Queen s University, Kingston, Ontario, Canada
    Crit Care Med 39:1985-91. 2011
    ..New evidence on subglottic secretion drainage as a preventive measure for ventilator-associated pneumonia has been recently published and to consider the evidence in totality, we conducted an updated systematic review and meta-analysis...
  8. doi request reprint Determinants of outcome in patients with a clinical suspicion of ventilator-associated pneumonia
    John G Muscedere
    Department of Medicine, Queen s University, Kingston, Ontario, Canada K7L 2V7
    J Crit Care 23:41-9. 2008
    ..In addition, we studied the impact of the clinical and microbiological components of CSVAP on the processes of care and outcomes...
  9. doi request reprint The impact of ventilator-associated pneumonia on the Canadian health care system
    John G Muscedere
    Queens University, Kingston, Canada K7L 2V7
    J Crit Care 23:5-10. 2008
    ..Using published data and information from public health care providers, we sought to determine the impact of VAP on the Canadian health care system...